Novo Nordisk A/S

Europe's best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts…
Read More...

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, Sept. 15,…
Read More...

Two employees in pharmaceutical industry wearing protective gloves, mask, cap and white suit seen standing by the…
Read More...

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts…
Read More...

Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by:…
Read More...

Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo…
Read More...

LONDON — European markets are expected to open in flat to negative territory as investors take stock of the volatile…
Read More...

Shares in Novo Nordisk surged 6% Tuesday, after the Wegovy maker secured approval of its GLP-1 pill — a world first.…
Read More...

The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo…
Read More...

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals…
Read More...